Xarelto (rivaroxaban) is a blood thinner prescribed to prevent and treat blood clots across a range of conditions, from irregular heart rhythms to post-surgical recovery. It belongs to a class of medications called direct oral anticoagulants, which have largely replaced older blood thinners like warfarin for many patients because they require less monitoring and have fewer dietary restrictions.
How Xarelto Works
Blood clots form through a chain reaction of proteins in your bloodstream. One protein, called factor Xa, sits at a critical junction in that chain. It acts as a catalyst that generates thrombin, the enzyme that actually builds the clot. Xarelto blocks factor Xa directly and reversibly, slowing clot formation without shutting down your clotting system entirely. It’s highly selective for this one target, with more than 10,000 times greater affinity for factor Xa than for other similar proteins in the body.
Stroke Prevention in Atrial Fibrillation
Atrial fibrillation (AFib) is the most common reason people take Xarelto long-term. In AFib, the upper chambers of the heart quiver instead of beating in a coordinated rhythm. Blood can pool in those chambers, form clots, and travel to the brain, causing a stroke. Xarelto reduces that risk by keeping blood flowing more freely.
The standard dose for AFib is 20 mg once daily, taken with food. For people with reduced kidney function, the dose drops to 15 mg once daily, since the kidneys play a role in clearing the drug from the body. Most people with AFib take Xarelto indefinitely.
Treating Blood Clots in the Legs and Lungs
Xarelto treats two closely related conditions: deep vein thrombosis (DVT), where a clot forms in a deep vein, usually in the leg, and pulmonary embolism (PE), where a clot travels to the lungs. Both can be dangerous, and PE can be life-threatening.
Treatment starts with a higher dose for the first three weeks: 15 mg twice daily, taken with food. After that initial period, you switch to 20 mg once daily. The total length of treatment depends on what caused the clot and your risk of it happening again. Some people take it for three to six months, while others with recurring clots or ongoing risk factors stay on it longer. Xarelto is also approved specifically to reduce the chance of DVT or PE coming back after an initial course of treatment.
Preventing Clots After Joint Replacement
Hip and knee replacement surgeries carry a significant risk of blood clots forming in the legs during recovery, when you’re less mobile. Xarelto is approved to prevent these clots at a lower dose of 10 mg once daily, which can be taken with or without food.
The first dose is given 6 to 10 hours after surgery, once any surgical bleeding has stopped. For knee replacement, the typical course lasts 2 weeks. For hip replacement, it extends to 5 weeks, reflecting the longer period of elevated clot risk associated with that procedure.
Protection for Coronary and Peripheral Artery Disease
Xarelto is also approved at a much lower dose, 2.5 mg twice daily, for people with chronic coronary artery disease (narrowed heart arteries) or peripheral artery disease (narrowed arteries in the legs). At this dose, it’s taken alongside low-dose aspirin (75 to 100 mg daily) to reduce the risk of major cardiovascular events like heart attack and stroke.
This combination works because it targets two different parts of clot formation: aspirin affects platelets, while Xarelto slows the clotting cascade. The tradeoff is a higher risk of bleeding compared to aspirin alone, so this regimen is typically reserved for people whose cardiovascular risk is high enough to justify it.
Hospitalized Patients With Acute Illness
People hospitalized for serious medical conditions like pneumonia, heart failure, or severe infections face elevated clot risk due to immobility and inflammation. Xarelto is approved for clot prevention in these acutely ill patients as well, though this use is less common than the others and is typically managed by the hospital care team.
Why Food Matters With Xarelto
One practical detail that makes a real difference in how well Xarelto works: the 15 mg and 20 mg tablets need to be taken with food. Without it, your body absorbs significantly less of the drug. The 20 mg dose, for instance, sees a 39% increase in total absorption and a 76% increase in peak blood levels when taken with a meal. The 10 mg tablet, used after surgery, doesn’t have this issue and can be taken with or without food.
This isn’t a minor footnote. If you’re taking the higher doses on an empty stomach, you may not be getting the protection you need.
Bleeding Risk
The most significant risk with any blood thinner is bleeding. Because Xarelto reduces your body’s ability to form clots, cuts may take longer to stop bleeding, and internal bleeding becomes a more serious concern. In clinical studies of patients with atrial fibrillation and severe kidney disease, rivaroxaban was associated with a major bleeding rate of 4.9 per 100 person-years, compared to 2.9 per 100 person-years for warfarin. That’s a meaningful difference, and it’s one reason your prescriber will weigh your individual bleeding risk against the benefits of clot prevention.
Signs of serious bleeding include unusual bruising, blood in your urine or stool, coughing up blood, or feeling unusually dizzy or weak. If Xarelto causes a life-threatening bleed, a specific reversal agent called andexanet alfa can be given in an emergency setting to counteract the drug’s effects. This antidote was the first approved for factor Xa inhibitors like Xarelto.
Generic Availability
The FDA has approved generic versions of rivaroxaban, making it the second direct oral anticoagulant to receive generic authorization after apixaban. However, generic forms are still not available to consumers in the U.S. due to ongoing patent protections. For now, Xarelto remains a brand-name medication, which can affect cost depending on your insurance coverage.